AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
InnoCan Pharma Corporation
CAD 2.35
-$5.18 (-68.79%)
CNQ · 14 Sep 2026 16:58 UTC
Previous Close
CAD 2
Day Range
CAD 2CAD 2.35
Year Range
CAD 2CAD 21
Market Cap
10.57M
AVG Volume
1.33K
Trailing/Forward PE
-8.15/-
PEG ratio
0.08
Dividend Yield
-
Next Earnings Date
2026-11-25
Primary Exchange
Canadian Securities Exchange
Video analysis: INNO.CN
All videosNo video analysis for this stock yet. Request one from our team.
News: INNO.CN
Innocan Pharma Announces Private Placement of Units
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete
Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust
/PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), through B.I. Sky Global Ltd., the consumer wellness
Similar companies
-
Decibel Cannabis Company Inc.
DB.V
·
Toronto Stock Exchange Ventures
Compare
-
Vext Science, Inc.
VEXT.CN
·
Canadian Securities Exchange
Compare
-
Planet 13 Holdings Inc.
PLTH.CN
·
Canadian Securities Exchange
Compare
-
iAnthus Capital Holdings, Inc.
IAN.CN
·
Canadian Securities Exchange
Compare
-
MariMed Inc.
MRMD.CN
·
Canadian Securities Exchange
Compare
-
BioNxt Solutions Inc.
BNXT.CN
·
Canadian Securities Exchange
Compare